Health

Texas Cardiac Arrhythmia Institute physician led international workshop on cardiac arrhythmias

The executive medical director of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently led Venice Arrhythmias 2022, a biennial international workshop on cardiac arrhythmias held in Venice, Italy from October 13 to October 15, 2022. As Venice Arrhythmias president, Andrea Natale, M.D., F.A.C.C., F.H.R.S., F.E.S.C., organized the programming for the event. More than 600 attendees from […]

thaipr.net

27 ต.ค. 65

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

Following our communication last  week “MedAlliance to be acquired by Cordis”, MedAlliance is pleased to make the following announcement:  SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial.  This is the first sustained limus release coronary drug eluting balloon (DEB) to receive FDA IDE approval…

thaipr.net

26 ต.ค. 65

SIRONA completes enrollment – A leap in the DCB treatment of femoropopliteal arterial disease

Concept Medical Inc. announces the successful completion of the SIRONA – World’s first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA – Concept Medical Inc.) V/S Paclitaxel DCB angioplasty for the treatment of peripheral artery disease in the femoropopliteal vessel segment. The prospective, multi-center, head-to-head, corelab adjudicated RCT […]

thaipr.net

25 ต.ค. 65

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML

Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submission with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for the use of the LeukoStrat® CDx FLT3 Mutation Assay as the companion diagnostic for Daiichi Sankyo’s investigational drug quizartinib. The assay is used for the identification of […]

thaipr.net

25 ต.ค. 65

AFTER 30 YEARS — NEW GUIDELINES FOR WEIGHT-LOSS SURGERY

Medical Groups Replace Outdated Consensus Statement that  Overly Restricts Access to Modern-Day Weight-Loss Surgery Two of the world’s leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among a slew of recommendations expand patient eligibility for weight-loss surgery and endorse metabolic surgery for patients with type 2 diabetes beginning at a […]

thaipr.net

25 ต.ค. 65

MGI Contributes to Thailand’s Roadmap for Genomic Medicine in Genomics Thailand Initiative

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the supply of its products* to support the sequencing of the genomes of 50,000 Thai individuals as part of the Genomics Thailand Initiative, which focuses on increasing the country’s competitiveness in genomic medicine research and […]

thaipr.net

21 ต.ค. 65

MedAlliance to be Acquired by Cordis

Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of $200M, regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029 for a total consideration of up to $1.135 […]

thaipr.net

20 ต.ค. 65
1 … 59 60 61 62 63 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.